Brief: Sequana Medical FY Net Loss Widens At Eur 32.56 Million, Issues New Shares

Sequana Medical NV

20/03/2024 15:31

March 20 (Reuters) - Sequana Medical NV  SEQUA.BR :
    * ANNOUNCES TODAY LAUNCH OF AN EQUITY OFFERING TO RAISE AN
AMOUNT
OF UP TO APPROXIMATELY EUR 12 MILLION BY MEANS OF A PRIVATE
PLACEMENT OF NEW SHARES VIA AN ACCELERATED BOOKBUILD OFFERING
    * LAUNCH OF AN EQUITY OFFERING TO RAISE AN AMOUNT OF UP TO
APPROXIMATELY EUR 12 MILLION BY MEANS OF A PRIVATE PLACEMENT OF
NEW SHARES
    * NET PROCEEDS FROM OFFERING ARE EXPECTED TO EXTEND CURRENT
CASH
RUNWAY OF COMPANY TO END OF Q3 2024
    * NET LOSS FOR FY 2023: NET LOSS INCREASED FROM EUR 30.76
MILLION
IN 2022 TO EUR 32.56 MILLION IN 2023
    * EBIT BROADLY UNCHANGED FROM LOSS OF EUR 28.09 MILLION IN
2022 TO
LOSS OF EUR 28.86 MILLION IN 2023
    * COMPANY ENDED 2023 WITH A TOTAL CASH AND CASH EQUIVALENTS
AMOUNT
OF EUR 2.6 MILLION (2022: EUR 18.9 MILLION)

Source text for Eikon:  ID:nGNEbMQK6D 
Further company coverage:  SEQUA.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))